Aktienanalyse zu Zepp Health Corp (ZEPP)ZEPPZepp Health Corp

Zepp Health Corp, formerly Huami Corp, is a Netherlands-based company primarily engaged in the consumer electronics and digital health technology industry. The Company focuses on developing smart wearable devices and digital health management platforms. Their key product is the Zepp Digital Health Management Platform, which is a cloud-based system integrating smart devices, biometric sensors, Artificial Intelligence (AI) chips, and data algorithms. It aims to provide users with 24/7 actionable insights to support health, fitness, and wellness management. The platform powers a range of products including smartwatches, fitness bands, smart rings, and hearables under the Amazfit and Zepp brand names. Additionally, the Company offers AI-driven services such as Zepp Aura for sound-based wellness and Zepp Clarity for hearing health. The Company has one reportable segment: Amazfit-branded products. It operates in the Technology sector (ELECTRONIC COMPUTERS industry).

Zepp Health Corp is not a good buy right now due to a current price of $3.02 and a concerning RSI of 5.838, indicating extreme oversold conditions. The company has reported a staggering year-to-date change of -89.23% and a one-year change of -93.94%, reflecting severe financial distress. Additionally, the forward P/E ratio stands at 3.124, which may seem low but is overshadowed by the company's ongoing net losses, including a net loss of $11.33 million in Q2 2026. The main risk is the widening operating loss and declining revenue expectations for Q3 2026, which could further impact stock performance.